Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Effect of Acorus calamus L. Polysaccharide on CD274 and CD326 Expression by Lewis Lung Carcinoma Cells in Mice.

Lopatina KA, Safonova EA, Nevskaya KV, Stakheeva MN, Gur'ev AM, Zueva EP, Razina TG, Amosova EN, Krylov SG, Belousov MV.

Bull Exp Biol Med. 2017 Nov;164(1):102-105. doi: 10.1007/s10517-017-3934-4. Epub 2017 Nov 10.

PMID:
29124538
2.

Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.

Inaguma S, Lasota J, Felisiak-Golabek A, Kowalik A, Wang Z, Zieba S, Kalisz J, Ikeda H, Miettinen M.

J Pathol Clin Res. 2017 Oct 7;3(4):268-278. doi: 10.1002/cjp2.81. eCollection 2017 Oct.

3.

Relationship of tumor PD-L1 (CD274) expression with lower mortality in lung high-grade neuroendocrine tumor.

Inamura K, Yokouchi Y, Kobayashi M, Ninomiya H, Sakakibara R, Nishio M, Okumura S, Ishikawa Y.

Cancer Med. 2017 Oct;6(10):2347-2356. doi: 10.1002/cam4.1172. Epub 2017 Sep 18.

4.

Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.

Inaguma S, Lasota J, Wang Z, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Miettinen M.

Hum Pathol. 2017 Aug 12. pii: S0046-8177(17)30269-1. doi: 10.1016/j.humpath.2017.04.032. [Epub ahead of print]

PMID:
28811252
5.

CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.

Clavé S, Pijuan L, Casadevall D, Taus Á, Gimeno J, Hernández-Llodrà S, Rodríguez-Rivera M, Lorenzo M, Menéndez S, Albanell J, Espinet B, Arriola E, Salido M.

Histopathology. 2017 Aug 10. doi: 10.1111/his.13339. [Epub ahead of print]

PMID:
28795418
6.

Genome-wide gene expression profiling reveals that CD274 is up-regulated new-onset type 1 diabetes mellitus.

Fang C, Huang Y, Pei Y, Zhang HH, Chen X, Guo H, Li S, Ji X, Hu J.

Acta Diabetol. 2017 Aug;54(8):757-767. doi: 10.1007/s00592-017-1005-y. Epub 2017 Jun 2.

PMID:
28577136
7.

Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.

Hamada T, Cao Y, Qian ZR, Masugi Y, Nowak JA, Yang J, Song M, Mima K, Kosumi K, Liu L, Shi Y, da Silva A, Gu M, Li W, Keum N, Zhang X, Wu K, Meyerhardt JA, Giovannucci EL, Giannakis M, Rodig SJ, Freeman GJ, Nevo D, Wang M, Chan AT, Fuchs CS, Nishihara R, Ogino S.

J Clin Oncol. 2017 Jun 1;35(16):1836-1844. doi: 10.1200/JCO.2016.70.7547. Epub 2017 Apr 13.

PMID:
28406723
8.

Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer.

Lee KS, Kwak Y, Ahn S, Shin E, Oh HK, Kim DW, Kang SB, Choe G, Kim WH, Lee HS.

Cancer Immunol Immunother. 2017 Jul;66(7):927-939. doi: 10.1007/s00262-017-1999-6. Epub 2017 Apr 12.

PMID:
28405764
9.

PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.

Budczies J, Mechtersheimer G, Denkert C, Klauschen F, Mughal SS, Chudasama P, Bockmayr M, Jöhrens K, Endris V, Lier A, Lasitschka F, Penzel R, Dietel M, Brors B, Gröschel S, Glimm H, Schirmacher P, Renner M, Fröhling S, Stenzinger A.

Oncoimmunology. 2017 Jan 27;6(3):e1279777. doi: 10.1080/2162402X.2017.1279777. eCollection 2017.

PMID:
28405504
10.

Tumor cell-intrinsic CD274/PD-L1: A novel metabolic balancing act with clinical potential.

Clark CA, Gupta HB, Curiel TJ.

Autophagy. 2017 May 4;13(5):987-988. doi: 10.1080/15548627.2017.1280223. Epub 2017 Apr 3.

PMID:
28368722
11.

<i>PD-L1</i> (<i>CD274</i>) promoter methylation predicts survival in colorectal cancer patients.

Goltz D, Gevensleben H, Dietrich J, Dietrich D.

Oncoimmunology. 2016 Nov 10;6(1):e1257454. doi: 10.1080/2162402X.2016.1257454. eCollection 2017.

12.

CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma.

Kwiecinska A, Tsesmetzis N, Ghaderi M, Kis L, Saft L, Rassidakis GZ.

Br J Haematol. 2016 Nov 23. doi: 10.1111/bjh.14432. [Epub ahead of print] No abstract available.

PMID:
27879989
13.

CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling.

Fang X, Chen C, Xia F, Yu Z, Zhang Y, Zhang F, Gu H, Wan J, Zhang X, Weng W, Zhang CC, Chen GQ, Liang A, Xie L, Zheng J.

J Hematol Oncol. 2016 Nov 17;9(1):124.

14.

PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia.

Goltz D, Gevensleben H, Grünen S, Dietrich J, Kristiansen G, Landsberg J, Dietrich D.

Leukemia. 2017 Mar;31(3):738-743. doi: 10.1038/leu.2016.328. Epub 2016 Nov 14. No abstract available.

PMID:
27840427
15.

Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.

Inaguma S, Lasota J, Wang Z, Felisiak-Golabek A, Ikeda H, Miettinen M.

Mod Pathol. 2017 Feb;30(2):278-285. doi: 10.1038/modpathol.2016.185. Epub 2016 Nov 4.

PMID:
27813511
16.

Genomic Amplification of <i>CD274</i> (PD-L1) in Small-Cell Lung Cancer.

George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel AH, Uchida S, Watanabe SI, Nishikawa R, Noguchi M, Peifer M, Jang SJ, Petersen I, Büttner R, Harris CC, Yokota J, Thomas RK, Kohno T.

Clin Cancer Res. 2017 Mar 1;23(5):1220-1226. doi: 10.1158/1078-0432.CCR-16-1069. Epub 2016 Sep 12.

PMID:
27620277
17.

PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker.

Guo L, Li W, Zhu X, Ling Y, Qiu T, Dong L, Fang Y, Yang H, Ying J.

Springerplus. 2016 Jun 21;5(1):805. doi: 10.1186/s40064-016-2513-x. eCollection 2016.

18.

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

Masugi Y, Nishihara R, Yang J, Mima K, da Silva A, Shi Y, Inamura K, Cao Y, Song M, Nowak JA, Liao X, Nosho K, Chan AT, Giannakis M, Bass AJ, Hodi FS, Freeman GJ, Rodig S, Fuchs CS, Qian ZR, Ogino S.

Gut. 2017 Aug;66(8):1463-1473. doi: 10.1136/gutjnl-2016-311421. Epub 2016 May 5.

PMID:
27196573
19.

Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.

Budczies J, Bockmayr M, Denkert C, Klauschen F, Gröschel S, Darb-Esfahani S, Pfarr N, Leichsenring J, Onozato ML, Lennerz JK, Dietel M, Fröhling S, Schirmacher P, Iafrate AJ, Weichert W, Stenzinger A.

Genes Chromosomes Cancer. 2016 Aug;55(8):626-39. doi: 10.1002/gcc.22365. Epub 2016 May 30.

PMID:
27106868
20.

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity.

Straub M, Drecoll E, Pfarr N, Weichert W, Langer R, Hapfelmeier A, Götz C, Wolff KD, Kolk A, Specht K.

Oncotarget. 2016 Mar 15;7(11):12024-34. doi: 10.18632/oncotarget.7593.

Supplemental Content

Support Center